81

ASPIVIX Selected among the Top 100 Swiss startups 2020 and 25 startups in Canton de Vaud!

September 9, 2020

Share this story:

More from our blog

Aspivix Achieves New Milestone: Study Results Peer-Reviewed and Published in the International Journal of Gynecology & Obstetrics

Read More about Aspivix Achieves New Milestone: Study Results Peer-Reviewed and Published in the International Journal of Gynecology & Obstetrics

Leading the Way in Women’s Health Innovation

Read More about Leading the Way in Women’s Health Innovation

An unsung hero in Femtech

Read More about An unsung hero in Femtech

“Must IUD insertion really be this painful?”

Read More about “Must IUD insertion really be this painful?”

New Scientific Publication in the International Journal of Gynecology & Obstetrics

Read More about New Scientific Publication in the International Journal of Gynecology & Obstetrics

Real stories, real change in women’s health

Read More about Real stories, real change in women’s health

Carevix® Featured in Innovation Healthcare Switzerland: Redefining Comfort and Precision in Women’s Health

Read More about Carevix® Featured in Innovation Healthcare Switzerland: Redefining Comfort and Precision in Women’s Health

Carevix® Featured in USA Today: It was named one of health’s best inventions of 2024. It’s finally available in the US.

Read More about Carevix® Featured in USA Today: It was named one of health’s best inventions of 2024. It’s finally available in the US.

Aspivix Marketing Team Award Winner Oncon 2025

Read More about Aspivix Marketing Team Award Winner Oncon 2025

Aspivix published in BMJ Sexual & Reproductive Health

Read More about Aspivix published in BMJ Sexual & Reproductive Health